4//SEC Filing
Woo Liyuan 4
Accession 0001628280-23-029142
CIK 0001818093other
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 6:46 PM ET
Size
8.3 KB
Accession
0001628280-23-029142
Insider Transaction Report
Form 4
Beauty Health CoSKIN
Woo Liyuan
Chief Financial Officer
Transactions
- Disposition to Issuer
Stock Options (right to buy)
2023-08-10−372,000→ 0 totalExercise: $12.85Exp: 2031-05-06→ Common Stock (372,000 underlying) - Award
Stock Options (right to buy)
2023-08-10+372,000→ 372,000 totalExercise: $12.85Exp: 2025-08-10→ Common Stock (372,000 underlying)
Footnotes (1)
- [F1]The transaction involves an amendment of an outstanding option, resulting in the cancellation of the "old" option and the grant of a replacement option. The option was originally granted on May 6, 2021 and represented a grant of 744,000 shares of common stock underlying the option under the issuer's 2021 Incentive Award Plan (the "Plan"). As of Aug 10, 2023, the date of the Reporting Person's separation from the issuer (the "Separation Date"), 372,000 shares underlying the option, had vested (the "Vested Options") and the other 372,000 shares underlying the option, had not vested (the "Unvested Options"). Under the Plan, the Unvested Options were forfeited upon separation and the Vested Options would have to be exercised within 90 days of the Separation Date. However, pursuant to the Reporting Person's separation agreement, as filed in Exhibit 10.2 to the issuer's Current Report on Form 8-K filed on Aug 9, 2023, the expiration date of the Vested Options was extended to Aug 10, 2025.
Documents
Issuer
Beauty Health Co
CIK 0001818093
Entity typeother
Related Parties
1- filerCIK 0001499747
Filing Metadata
- Form type
- 4
- Filed
- Aug 10, 8:00 PM ET
- Accepted
- Aug 11, 6:46 PM ET
- Size
- 8.3 KB